Animal studies of prophylaxis

American Journal of Medicine

Volumn 102, Issue 5 B, 1997, Pages 39-44

  Black, Roberta J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXY 3' HYDROXYMETHYLCYTIDINE; 3' AZIDO 2',3' DIDEOXYURIDINE; 3' FLUOROTHYMIDINE; ADEFOVIR; ALPHA INTERFERON; ANTIRETROVIRUS AGENT; STAVUDINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CHEMOPROPHYLAXIS; CONFERENCE PAPER; DOSE TIME EFFECT RELATION; DRUG EFFICACY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS STRAIN;

ADENINE; ANIMALS; ANTI-HIV AGENTS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; INTERFERON-ALPHA; LENTIVIRUS INFECTIONS; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; RETROVIRIDAE INFECTIONS; REVERSE TRANSCRIPTASE INHIBITORS; ZIDOVUDINE;

EID: 0030844266     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00059-4     Document Type: Conference Paper

References (19)

1. Ruprecht RM, Mullaney S, Bernard LD, Gama Sosa MA, Hom RC, Finberg RW. Vaccination with a live retrovirus: the nature of the protective immune response. Proc Natl Acad Sci USA 1990;87:5558-5562.
2. Ruprecht RM, Chou T-C, Chipty F, et al. Interferon-α and 3′-azido-3′-deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposure. J AIDS. 1990;3:591-600.
3. + immune T cells. J Virol. 1991;65:220-224.
4. Ruprecht RM, Bronson R. Chemoprevention of retroviral infection: success is determined by virus inoculum strength and cellular immunity. DNA Cell Biol. 1994;13:59-66.
5. Fazely F, Haseltine WA, Rodger RF, Ruprecht RM. Postexposure chemoprophylaxis with ZDV or ZDV combined with interferon-α: failure after inoculating rhesus monkeys with a high dose of SIV. J AIDS. 1991;4:1093-1097.
6. Martin LN, Murphey-Corb M, Soike KF, Davison-Fairburn B, Baskin GB. Effects of initiation of 3′-azido,3′-deoxythymidine (Zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus. J Inf Dis. 1993;168:625-635.
7. McClure HM, Anderson DC, Ansari AA, Fultz PN, Klumpp SA, Schinazi RF. Nonhuman primate models for evaluation of AIDS therapy. In: AIDS: Anti-HIV Agents, Therapies and Vaccines. Ann. NY Acad Sci. 1990;616:287-298.
8. Lundgren B, Böttiger D, Ljungdahl-Ståhle E, et al. Antiviral effects of 3′-fluorothymidine and 3′-azidothymidine in cynomolgus monkeys infected with simian immunodeficiency virus. J AIDS. 1991;4:489-498.
9. Böttiger D, Ljungdahl-Ståhle B, Öberg B. Treatment of acute SIV infection in cynomolgus monkeys with 2′,3′-dideoxyinosine (ddl) and 2′,3′-dideoxythymidiene (d4T). Antiviral Chem Chemother. 1991;2:357-361.
10. Murphey-Corb M, Martin LN, Davison-Fairburn B, et al. A formalin-inactivated whole SIV vaccine confers protection in macaques. Science. 1989;246:1293-1297.
11. Böttiger D, Putkonen P, Öberg B. Prevention of HIV-2 and SIV infections in cynomolgus macaques by prophylactic treatment with 3′-fluorothymidine. AIDS Res Hum Retrov. 1992;8:1235-1238.
12. 287 infected macaques. (Abstr. 214.) Third Conference on Retroviruses and Opportunistic Infections, January 28-February 1, 1996, Washington, DC.
13. Van Rompay KKA, Otsyula MG, Marthas ML, Miller CJ, McChesney MB, Pedersen NC. Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS. Antimicrob Agents Chemother. 1995;39:125-131.
14. Van Rompay KKA, Marthas ML, Ramos RA, et al. Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: Oral 3′-azido′3′-deoxythymidine prevents SIV infection. Antimicrob Agents Chemother. 1992;36:2381-2386.
15. Haigwood NL, Watson A, Sutton WF, et al. Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. Immunol Letters. 1996;51:107-114.
16. Tsai C-C, Follis KE, Sabo A, et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science. 1995;270:1197-1199.
17. Tsai C-C, Follis KE, Grant RF, et al. Effect of dosing frequency on ZDV prophylaxis in macaques infected with simian immunodeficiency virus. J AIDS. 1993;6:1086-1092.
18. sm and HIV-2 infections in cynomolgus monkeys by pre- and postexposure treatment with BEA-005. (Submitted).
19. Shin C-C, Kaneshima H, Rabin L, et al. Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner. J Infect Dis. 1991;163:625-627.